EW
30
-2
AMT
56
-3
CME
48
2
NWL
54
5
EQIX
70
5
LYB
48
2
GRMN
48
2
JCI
54
2
JPM
69
3
ROK
46
2
GIS
31
2
EIX
67
5
MAR
68
3
ED
39
2
ORLY
65
4
KIM
73
4
PM
54
4
VTR
52
3
SYF
92
7
NWS
47
2
EW
30
-2
AMT
56
-3
CME
48
2
NWL
54
5
EQIX
70
5
LYB
48
2
GRMN
48
2
JCI
54
2
JPM
69
3
ROK
46
2
GIS
31
2
EIX
67
5
MAR
68
3
ED
39
2
ORLY
65
4
KIM
73
4
PM
54
4
VTR
52
3
SYF
92
7
NWS
47
2
Financhill
Back

Vivos Therapeutics 10K Form

Sell
40

VVOS
Vivos Therapeutics

Last Price:
2.43
Seasonality Move:
35.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VVOS News And Ratings

See the #1 stock for the next 7 days that we like better than VVOS

VVOS Financial Statistics

Sales & Book Value

Annual Sales: $13.8M
Cash Flow: $-3.11M
Price / Cash Flow: 0
Annual Sales: $1.87
Price / Book: 1.32

Profitability

EPS (TTM): -7.03000
Net Income (TTM): $-12.05M
Gross Margin: $8.27M
Return on Equity: -634.48%
Return on Assets: -96.45%

Vivos Therapeutics Earnings Forecast

Key Vivos Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 6 years for VVOS is 59.93%.
  • The Selling, General & Administrative Expenses for VVOS have been equal to 180.76% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of VVOS is -98.42% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Vivos Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: VVOS
Website: vivos.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.18
Quick Ratio: 1.1

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VVOS Technical Analysis vs Fundamental Analysis

Sell
40
Vivos Therapeutics (VVOS) is a Sell

Is Vivos Therapeutics a Buy or a Sell?